ARCHIVES

Zevalin Regimen Effective In Mantle Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 27 No. 1 | January 30, 2004

Download PDF Visit The Full Archive

Related Articles

DRCCA Board Gets Tough on Concept Proposals, Okays Several Anyway

November 4, 1983

RFAs: Patient Outcomes “5-A-Day” Program

April 10, 1992

ASCO Draft Recommendations Define Meaningful Trial Outcomes

April 26, 2013

HHS Secretary Rebukes Task Force Guidelines On Breast Cancer Screening

November 29, 2009

In Brief: Reducing Doses Cuts Cure Rate Every Time, DeVita Says; Hyperthermia Use In Cancer Being Assessed

April 6, 1984

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

March 1, 2002